Last quarter (Q4 2022), Spire Healthcare's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Spire Healthcare's net income was £―. See Spire Healthcare’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	£ 1.20B	£ 1.11B	£ 919.90M	£ 980.80M	£ 931.10M
Cost of Revenue	-	£ 660.10M	£ 615.00M	£ 464.10M	£ 529.40M	£ 497.60M
Gross Profit	-	£ 538.40M	£ 491.20M	£ 455.80M	£ 451.40M	£ 433.50M
Operating Expense	-	£ 445.20M	£ 411.20M	£ 389.10M	£ 353.80M	£ 336.80M
Operating Income	-	£ 93.20M	£ 80.00M	£ 66.70M	£ 97.60M	£ 96.70M
Net Non Operating Interest Income Expense	-	£ -91.50M	£ 88.80M	£ -85.10M	£ -84.80M	£ -76.70M
Other Income Expense	-	£ -2.70M	-	-	-	-
Pretax Income	-	£ 3.90M	£ -1.90M	£ -231.00M	£ 9.60M	£ -5.60M
Tax Provision	-	£ -4.30M	£ 7.00M	£ 2.90M	£ 2.40M	£ -5.70M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ 8.60M	£ -9.70M	£ -233.90M	£ 7.20M	£ 100.00K
Basic EPS	-	£ 0.02	£ -0.02	£ -0.58	£ 0.02	£ 0.03
Diluted EPS	-	£ 0.02	£ -0.02	£ -0.58	£ 0.02	£ 0.03
Basic Average Shares	-	£ 402.76M	£ 400.85M	£ 400.84M	£ 400.83M	£ 400.82M
Diluted Average Shares	-	£ 402.68M	£ 400.85M	£ 400.84M	£ 407.31M	£ 402.11M
Dividend Per Share	-	£ 0.01	-	£ 0.00	£ 0.04	£ 0.04
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	£ -0.05	£ 0.02	£ 0.07
Reported Normalized Diluted E P S	-	-	-	£ -0.05	£ 0.02	£ 0.07
Rent Expense Supplemental	-	-	-	£ 11.10M	£ 11.30M	£ 9.40M
Total Expenses	-	£ 1.11B	£ -1.03B	£ 853.20M	£ 883.20M	£ 834.40M
Net Income From Continuing And Discontinued Operation	-	£ 8.60M	£ -9.70M	£ -233.90M	£ 7.20M	£ 100.00K
Normalized Income	-	£ 2.20M	£ -7.34M	£ -61.69M	£ 9.60M	£ 20.84M
Interest Expense	-	-	-	£ 85.10M	£ 84.10M	£ 80.20M
EBIT	-	£ 89.80M	£ 85.90M	£ -145.90M	£ 93.70M	£ 74.60M
EBITDA	-	£ 187.70M	£ 85.90M	£ -51.90M	£ 185.30M	£ 163.50M

Currency in GBP

Spire Healthcare Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing